» Articles » PMID: 35042214

Multimorbidity and Readmissions in Older People with Acute Coronary Syndromes

Overview
Journal Cardiology
Date 2022 Jan 18
PMID 35042214
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: This study aimed to examine the multimorbidity as well as the 30-day and 1-year readmission rates in a large, unselected cohort of elderly patients with acute coronary syndrome (ACS).

Methods And Results: All patients ≥70 years hospitalized due to ACS during January 1, 2006, to December 31, 2013, and registered in the SWEDEHEART registry were included. In-hospital multimorbidity and disease burden were determined. Outcomes included 30-day and 1-year all-cause mortality, any readmission, and readmissions due to ACS, heart failure, ischaemic stroke or transient ischaemic attack (TIA), and bleeding events. Out of 80,176 patients, 25.6% had ST-elevation myocardial infarction (STEMI) and 74.4% non-ST-segment elevation ACS (NSTE-ACS). The mean age was 79.8 (±6.4 standard deviation) and 43.4% were women. Multimorbidity, or two chronic diseases, was present in 67.7%, thereof in 53.0% of STEMI patients and 72.7% of NSTE-ACS patients. In-hospital mortality was 7.0%. Of the 74,577 patients who survived to discharge, 24.6% were readmitted within 30 days and 59.5% were readmitted during the following year. Multimorbid patients had a higher risk of readmissions than those without multimorbidity. Multimorbid STEMI patients were admitted the following year in 56.2% of cases compared to 44.5% of STEMI patients without multimorbidity, adjusted odds ratio (OR) 1.35 (95% confidence interval: 1.26-1.45). Multimorbid patients with NSTE-ACS were readmitted in 63.4% of cases the following year compared with 49.1% of those without multimorbidity, adjusted OR 1.42 (1.35-1.50). More than half of the readmissions were due to cardiovascular causes (ACS, stroke, TIA, or heart failure) or bleeding events.

Conclusions: Older people with ACS have a high multimorbidity burden and a high readmission rate both within 30 days and 1 year. Half of the readmissions were due to a cardiovascular event or a bleeding event. The presence of multimorbidity increases the risk of readmissions for patients with ACS. As hospital admissions are costly for the health care system and can include risks, especially for older patients, there may be opportunities in better risk stratifying this group at discharge for subsequent decrease in readmission rates.

Citing Articles

Management of Acute Coronary Syndromes in Older People: Comprehensive Review and Multidisciplinary Practice-Based Recommendations.

Narendren A, Whitehead N, Burrell L, Yudi M, Yeoh J, Jones N J Clin Med. 2024; 13(15).

PMID: 39124683 PMC: 11312870. DOI: 10.3390/jcm13154416.

References
1.
Covinsky K, Palmer R, Fortinsky R, Counsell S, Stewart A, Kresevic D . Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J Am Geriatr Soc. 2003; 51(4):451-8. DOI: 10.1046/j.1532-5415.2003.51152.x. View

2.
Barnett K, Mercer S, Norbury M, Watt G, Wyke S, Guthrie B . Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012; 380(9836):37-43. DOI: 10.1016/S0140-6736(12)60240-2. View

3.
Aubert C, Schnipper J, Fankhauser N, Marques-Vidal P, Stirnemann J, Auerbach A . Patterns of multimorbidity associated with 30-day readmission: a multinational study. BMC Public Health. 2019; 19(1):738. PMC: 6567629. DOI: 10.1186/s12889-019-7066-9. View

4.
Walker D, Gale C, Lip G, Martin-Sanchez F, McIntyre H, Mueller C . Editor's Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care. 2018; 7(2):176-193. DOI: 10.1177/2048872618758931. View

5.
Jernberg T, Attebring M, Hambraeus K, Ivert T, James S, Jeppsson A . The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010; 96(20):1617-21. DOI: 10.1136/hrt.2010.198804. View